Verona Pharma American Depositary Share Operating Expenses 2017-2024 | VRNA

Verona Pharma American Depositary Share operating expenses for the twelve months ending December 31, 2024 were $0.197B, a 191.41% increase year-over-year.

  • Verona Pharma American Depositary Share annual operating expenses for 2024 were $0.197B, a 191.41% increase from 2023.
  • Verona Pharma American Depositary Share annual operating expenses for 2023 were $0.068B, a 11.34% decline from 2022.
  • Verona Pharma American Depositary Share annual operating expenses for 2022 were $0.076B, a 32.75% decline from 2021.